Sfoglia per AUTORE
FUDA G
Collezione AOU Novara

  

Items : 6

The role of peripheral immunity in ALS: a population-based study. in Annals of clinical and translational neurology / Ann Clin Transl Neurol. 2023 Sep;10(9):1623-1632. doi: 10.1002/acn3.51853. Epub 2023 Jul 22.

2023
AOU Novara
AOU Città della Salute di Torino

Calvo A; Mazzini L; Casale F; Fuda G; Salamone P; Canosa A; Vasta R; Palumbo F; Bombaci A; Solero L; Daviddi M; Matteoni E; Cugnasco P; De Marchi F; Manera U; Grassano M; Moglia C; Chiò A;

Presymptomatic geographical distribution of ALS patients suggests the involvement of environmental factors in the disease pathogenesis. in Journal of neurology / J Neurol. 2023 Nov;270(11):5475-5482. doi: 10.1007/s00415-023-11888-8. Epub 2023 Jul 25.

2023
AOU Città della Salute di Torino
AOU Novara

Calvo A; Chiò A; Manera U; Moglia C; Mazzini L; De Marchi F; Canosa A; Palumbo F; Fuda G; Marchese G; De Marco G; Bombaci A; Grassano M; Matteoni E; De Mattei F; Cabras S; Di Pede F; Sgambetterra S; Callegaro S; Vasta R;

Brain (18)fluorodeoxyglucose-positron emission tomography changes in amyotrophic lateral sclerosis with TARDBP mutations. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2022 Sep;93(9):1021-1023. doi: 10.1136/jnnp-2021-328296. Epub 2022 Ma

2022
AOU Città della Salute di Torino
AOU Novara

Manera U; Chiò A; Pagani M; Grassano M; Gallone S; Matteoni E; Sbaiz L; Salamone P; Novara A; Arena V; Cabras S; Di Pede F; Fuda G; Palumbo F; Vasta R; Moglia C; Canosa A; Calvo A;

Tailoring patients' enrollment in ALS clinical trials: the effect of disease duration and vital capacity cutoffs. in Amyotrophic lateral sclerosis & frontotemporal degeneration / Amyotroph Lateral Scler Frontotemporal Degener. 2022 Feb;23(1-2):108-115. doi: 10.1080/21678421.2021

2022
AOU Città della Salute di Torino
AOU Novara

Calvo A; Moglia C; Mazzini L; De Marchi F; Mattei A; Launaro N; Cugnasco P; Grassano M; Fuda G; Salamone P; Vasta R; Torrieri MC; Manera U; Canosa A; Mora G; Chiò A;

Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis. in JAMA neurology / JAMA Neurol. 2021 Oct 1;78(10):1236-1248. doi: 10.1001/jamaneurol.2021.2598.

2021
ASL Cuneo 2
AOU Città della Salute di Torino
AOU Novara

Zollino M; Zucchi E; Volanti P; Vacchiano V; Vita G; Vasta R; Trojsi F; Tranquilli S; Tremolizzo L; Tedeschi G; Ticca A; Torriello A; Spataro R; Tanel R; Simonini C; Sbaiz L; Sideri R; Simone I; Santarelli M; Salvi F; Salivetto M; Riva N; Russo M; Sabatelli M; Salamone P; Riolo G; Ricci C; Quattrini A; Pozzi S; et alii...

G-CSF (filgrastim) treatment for amyotrophic lateral sclerosis: protocol for a phase II randomised, double-blind, placebo-controlled, parallel group, multicentre clinical study (STEMALS-II trial). in BMJ open / BMJ Open. 2020 Mar 24;10(3):e034049. doi: 10.1136/bmjopen-2019-034049.

2020
AOU Città della Salute di Torino
AOU Novara

Calvo A; Moglia C; Simone IL; Mandrioli J; La Bella V; Mazzini L; Caponnetto C; Lunetta C; Marrali G; Casale F; Fuda G; Salamone P; Tarella C; Chio A;